| Diethylstilbestrol | Approved Withdrawn | YWHAB | 7529 |
upregulated | Diethylstilbestrol results in increased expression of YWHAB mRNA | 20q13.12 | |
| Diethylstilbestrol | Approved Withdrawn | ZMYND10 | 51364 |
downregulated | Diethylstilbestrol results in decreased expression of ZMYND10 mRNA | 3p21.31 | |
| Diflunisal | Approved | FOS | 2353 |
upregulated | Diflunisal results in increased expression of FOS mRNA | 14q24.3 | |
| Digoxin | Approved Investigational | ABCB1 | 5243 |
upregulated | Digoxin results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Artenimol | Approved Investigational | CDKN1A | 1026 |
upregulated | dihydroartemisinin results in increased expression of CDKN1A mRNA | 6p21.2 | |
| Artenimol | Approved Investigational | DDIT3 | 1649 |
upregulated | dihydroartemisinin results in increased expression of DDIT3 mRNA | 12q13.3 | |
| Artenimol | Approved Investigational | EGR1 | 1958 |
upregulated | dihydroartemisinin results in increased expression of EGR1 mRNA | 5q31.2 | |
| Artenimol | Approved Investigational | GADD45A | 1647 |
upregulated | dihydroartemisinin results in increased expression of GADD45A mRNA | 1p31.3 | |
| Artenimol | Approved Investigational | HMOX1 | 3162 |
upregulated | dihydroartemisinin results in increased expression of HMOX1 mRNA | 22q12.3 | |
| Artenimol | Approved Investigational | PMAIP1 | 5366 |
upregulated | dihydroartemisinin results in increased expression of PMAIP1 mRNA | 18q21.32 | |
| Anthralin | Approved | CSF2 | 1437 |
upregulated | Anthralin results in increased expression of CSF2 mRNA | 5q31.1 | |
| Anthralin | Approved | CXCL8 | 3576 |
upregulated | Anthralin results in increased expression of CXCL8 mRNA | 4q13.3 | |
| Anthralin | Approved | IL6 | 3569 |
upregulated | Anthralin results in increased expression of IL6 mRNA | 7p15.3 | |
| Anthralin | Approved | TNF | 7124 |
upregulated | Anthralin results in increased expression of TNF mRNA | 6p21.33 | |
| Calcitriol | Approved Investigational Nutraceutical | AARD | 441376 |
upregulated | Calcitriol results in increased expression of AARD mRNA | 8q24.11 | |
| Calcitriol | Approved Investigational Nutraceutical | ABAT | 18 |
upregulated | Calcitriol results in increased expression of ABAT mRNA | 16p13.2 | |
| Calcitriol | Approved Investigational Nutraceutical | ABCA1 | 19 |
upregulated | Calcitriol results in increased expression of ABCA1 mRNA | 9q31.1 | |
| Calcitriol | Approved Investigational Nutraceutical | ABCA12 | 26154 |
downregulated | Calcitriol results in decreased expression of ABCA12 mRNA | 2q35 | |
| Calcitriol | Approved Investigational Nutraceutical | ABCA3 | 21 |
upregulated | Calcitriol results in increased expression of ABCA3 mRNA | 16p13.3 | |
| Calcitriol | Approved Investigational Nutraceutical | ABCB1 | 5243 |
upregulated | Calcitriol results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Calcitriol | Approved Investigational Nutraceutical | ABCB10 | 23456 |
downregulated | Calcitriol results in decreased expression of ABCB10 mRNA | 1q42.13 | |
| Calcitriol | Approved Investigational Nutraceutical | ABCB5 | 340273 |
upregulated | Calcitriol results in increased expression of ABCB5 mRNA | 7p21.1 | |
| Calcitriol | Approved Investigational Nutraceutical | ABCC1 | 4363 |
upregulated | Calcitriol results in increased expression of ABCC1 mRNA | 16p13.11 | |
| Calcitriol | Approved Investigational Nutraceutical | ABCC3 | 8714 |
upregulated | Calcitriol results in increased expression of ABCC3 mRNA | 17q21.33 | |
| Calcitriol | Approved Investigational Nutraceutical | ABCD3 | 5825 |
upregulated | Calcitriol results in increased expression of ABCD3 mRNA | 1p21.3 | |